Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant - Priority Announcement: History of Medicine

University of Toronto

$75,000.00

Regulatory Policy and the Availability of Psychopharmacologic Agents

EF 2008-09

Résumé
According to its official mission statement, the U.S. Food and Drug Administration is responsible for protecting and advancing the public health by ensuring the availability of safe and effective products. Yet our previous research indicates that in the area of psychiatric drug regulation, the agency's policies have instead resulted in outcomes detrimental to the public health, specifically: 1. The approval of new drugs that are less effective than the best medications already available. 2. Drugs released much later in the United States than in other countries, or not licensed at all. The proposed research sets out to answer the question, How did these both of these problems arise? The study will use historical research methods to trace the evolution of regulatory policy and decision-making at the FDA, based largely on primary records either still in the agency's custody or transferred to the National Archives and Records Administration. Details concerning drugs licensed in the United States and other jurisdictions will be assembled from a wide variety of sources, including regulators' lists, national formularies, comparative studies, and medical/pharmacologic literature.
Programme
Operating Grant - Priority Announcement: History of Medicine
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
176786
Name
Shorter Edward
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Health Ethics, Law & Humanities
Projecttitle
Regulatory Policy and the Availability of Psychopharmacologic Agents
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$75,000
Cihrequipment2
$0
Programname2
Operating Grant - Priority Announcement: History of Medicine
Keyworddelim
Drug Regulation - History; Psychiatric Disorders - Drug Treatment; Psychopharmacology - History
Abstract
According to its official mission statement, the U.S. Food and Drug Administration is responsible for protecting and advancing the public health by ensuring the availability of safe and effective products. Yet our previous research indicates that in the area of psychiatric drug regulation, the agency's policies have instead resulted in outcomes detrimental to the public health, specifically: 1. The approval of new drugs that are less effective than the best medications already available. 2. Drugs released much later in the United States than in other countries, or not licensed at all. The proposed research sets out to answer the question, How did these both of these problems arise? The study will use historical research methods to trace the evolution of regulatory policy and decision-making at the FDA, based largely on primary records either still in the agency's custody or transferred to the National Archives and Records Administration. Details concerning drugs licensed in the United States and other jurisdictions will be assembled from a wide variety of sources, including regulators' lists, national formularies, comparative studies, and medical/pharmacologic literature.
Competitiondate
200809
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Shorter, Edward
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $75,000~ $0~